{"id":326349,"date":"2026-10-26T11:36:36","date_gmt":"2026-10-26T06:06:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=326349"},"modified":"2026-10-26T11:36:36","modified_gmt":"2026-10-26T06:06:36","slug":"pain-and-anti-malarial-brand-owner-contract-formulations-maker-and-branded-generics-exporter-stocks-roadmap-northstar-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pain-and-anti-malarial-brand-owner-contract-formulations-maker-and-branded-generics-exporter-stocks-roadmap-northstar-list\/","title":{"rendered":"3 Pain and Anti-Malarial Brand Owner, Contract Formulations Maker and Branded Generics Exporter Stocks With a Strong Future Roadmap: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals"},"content":{"rendered":"

Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals: ROE of 11.6% to 14.2% and FY22 to FY26 revenue CAGR of 9.9% to 19.5%. Prices as of 23 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three formulation and branded generic pharma stocks to watch are Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals. Their return on equity ranges from 11.6% to 14.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.9% to 19.5%. Ipca Laboratories has the highest return on equity at 14.2%, while Innova Captab has the fastest revenue growth at 19.5% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Formulation and branded generic pharma stocks bring together companies with a visible plan for the years ahead. Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals cover a pain and anti-malarial brand owner, a contract formulations maker and a branded generics exporter.<\/p>\n

This list covers three formulation and branded generic pharma stocks with complete current figures: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n